financetom
Business
financetom
/
Business
/
VSee Health Surges On Federal Approval, Opening Doors To More Government Partnerships
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
VSee Health Surges On Federal Approval, Opening Doors To More Government Partnerships
Oct 28, 2025 9:38 AM

VSee Health Inc. ( VSEE ) stock is trading higher on Monday, with a robust session volume of 187.07 million compared to the average volume of 5.22 million as per data from Benzinga Pro.

The AI-powered telehealth company received its Authority to Operate (ATO) at the FedRAMP High level from the U.S. Department of Health and Human Services (HHS).

The authorization also allows other federal agencies to use VSee where FedRAMP High is required.

The platform enables government partners to increase healthcare accessibility in remote locations and relieve medical surge events with:

Enterprise-grade encryption, HIPAA compliance, and HIE interoperability.

Hybrid telehealth and in-person workflows.

Rapid multi-site activation.

“With FedRAMP High ATO, agencies can deploy VSee for secure, real-world patient care-anytime, anywhere,” said Dr. Milton Chen, CEO of VSee. “This is a major step in expanding our government partnerships…”

In July, VSee deployed a secure, cloud-based telemedicine bridge for HHS ASPR (Assistant Secretary for Preparedness and Response).

It kept the only hospital on the U.S. Virgin Island of St. Croix (Governor Juan F. Luis Hospital) operational after a cyberattack crippled its IT systems, allowing the hospital to maintain emergency services and clear over 250 backlogged radiology studies within days.

VSee is also advancing AIMEE, a rural hospital transformation initiative to strengthen long-term rural health sustainability and disaster response programs via AI-enabled digital health infrastructure.

Last week, VSee Health ( VSEE ) reported second-quarter 2025 revenue of $3.4 million, up 98% year-over-year, with gross profit margin increasing from 45% to 47%.

Most recently, VSee Health ( VSEE ) said it eliminated over $5 million in legacy SPAC debt as it strengthens its balance sheet and positions itself for long-term growth.

Price Action: VSEE stock is up 204.18% at $1.87 at the last check on Tuesday.

Read Next:

Microsoft Stock Moves Higher On New Deal With OpenAI

Image created using artificial intelligence via DALL-E.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Peloton must face shareholder lawsuit over post-pandemic outlook
Peloton must face shareholder lawsuit over post-pandemic outlook
Aug 27, 2025
* US appeals court revives claims over inventory levels * Shareholders say Peloton inflated stock price * Dissenting judge expects eventual dismissal By Jonathan Stempel NEW YORK, Aug 27 (Reuters) - Peloton Interactive ( PTON ) must face a lawsuit claiming it defrauded shareholders by masking excess inventory of its home exercise equipment as the worst of the COVID-19 pandemic...
Webull Q2 Earnings Preview: Can Crypto Relaunch Help Boost Shares?
Webull Q2 Earnings Preview: Can Crypto Relaunch Help Boost Shares?
Aug 27, 2025
Webull Corporation ( BULL ) aims to highlight recent wins in cryptocurrency and its evolution since going public, as the company reports second-quarter financial results on Thursday after the market close. Earnings History Webull ( BULL ) went public in April after completing a SPAC merger. Shares soared after their debut with the company, among the top trending names among retail traders...
US approves potential $103.9 million sale of Sidewinder missiles to NATO
US approves potential $103.9 million sale of Sidewinder missiles to NATO
Aug 27, 2025
Aug 27 (Reuters) - The U.S. State Department has approved the potential sale of AIM-9X Sidewinder missiles and related equipment to the NATO Support and Procurement Agency for an estimated cost of $103.9 million, the Pentagon said on Wednesday. The principal contractor for the sale will be RTX Corp ( RTX ) , the Pentagon said in a statement. ...
Update: BioXcel Says BXCL501 At-Home Trial Meets Target; Shares Fall
Update: BioXcel Says BXCL501 At-Home Trial Meets Target; Shares Fall
Aug 27, 2025
03:09 PM EDT, 08/27/2025 (MT Newswires) -- (Updates with stock movement in headline, first paragraph) BioXcel Therapeutics ( BTAI ) shares were down over 22% in recent Wednesday trading even after the firm said a late-stage safety trial of BXCL501 met its at-home's primary endpoint. The firm said the trial met its primary endpoint of being well tolerated in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved